XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Awards (Tables)
9 Months Ended
Sep. 30, 2025
Stock-Based Awards  
Summary of assumptions used to determine fair value of stock options granted

    

Nine Months Ended

September 30, 

2025

2024

Risk-free interest rate

 

4.28

%

3.85

%

Expected term (in years)

 

6.2

6.0

Expected volatility

 

82.77

%

81.95

%

Expected dividend yield

 

0

%

0

%

Summary of stock option activity

    

    

    

Weighted

    

Weighted

Average

Average

Remaining

Aggregate

Number

Exercise

Contractual

Intrinsic

(In thousands, except share and per share data and years)

of Shares

Price

Term

Value

(in years)

Outstanding as of December 31, 2024

 

6,721,967

$

11.12

6.8

$

2,968

Granted

 

5,194,155

2.16

Forfeited and cancelled

 

(461,604)

7.34

Outstanding as of September 30, 2025

 

11,454,518

$

7.27

7.8

$

2,157

Options vested and expected to vest as of September 30, 2025

 

11,454,518

$

7.27

7.8

$

2,157

Options exercisable as of September 30, 2025

 

4,358,272

$

13.75

5.7

$

911

Summary of restricted stock units activity

Weighted

Average

Grant Date

Aggregate

Number

Fair Value

Intrinsic

(In thousands, except share and per share data)

of Shares

Per Share

Value

Outstanding as of December 31, 2024

2,276,151

$

5.12

Granted

2,093,713

2.23

Vested

(608,833)

8.32

$

1,355

Forfeited and cancelled

(86,200)

4.67

Outstanding as of September 30, 2025

3,674,831

$

2.96

Summary of stock-based compensation expense

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

(In thousands)

    

2025

    

2024

    

2025

    

2024

Cost of revenue

    

$

191

    

$

232

$

600

    

$

707

Research and development

964

1,124

3,255

2,192

General and administrative

 

1,705

 

1,648

 

5,603

 

5,097

Total stock-based compensation expense

$

2,860

$

3,004

$

9,458

$

7,996